SCHEMBL149682

SCHEMBL149682

O=P(O)(Oc1ccccc1)c1ccccc1.[Nd]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.64
CA4 P22748 3/20 0.64
CA5A P35218 3/20 0.64
CA12 O43570 2/20 0.64
CA1 P00915 2/20 0.64
CA7 P43166 2/20 0.64
CA9 Q16790 2/20 0.64
CA5B Q9Y2D0 2/20 0.64
SRC P12931 1/20 0.61
L3MBTL1 Q9Y468 2/20 0.59
TDP1 Q9NUW8 1/20 0.59
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CFTR P13569 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ANPEP P15144 2/20 0.43
LAP3 P28838 2/20 0.43
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL752987 0.98 CA2 (0.66) CA2CA4CA5ACA12CA1
Benzene SCHEMBL28297820 0.98 CA2 (0.66) CA2CA4CA5ACA12CA1
SCHEMBL672612 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
SCHEMBL29021952 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
SCHEMBL28773138 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
SCHEMBL639056 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
SCHEMBL673830 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
Hydrochloric Acid SCHEMBL5100853 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
SCHEMBL9584229 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1
SCHEMBL3963455 0.96 CA2 (0.64) CA2CA4CA5ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796800-B2 Process for producing polydienes BRIDGESTONE CORPORATION (JP) 2017-10-24 US claimed
US-20160108153-A1 PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (JP) 2016-04-21 US claimed
US-20100004413-A1 BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (JP) 2010-01-07 US claimed
EP-2075266-A2 Bulk polymerization process for producing polydienes Bridgestone Corporation (JP) 2009-07-01 EP claimed
EP-3969490-B1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS BRIDGESTONE CORP (JP) 2026-03-25 EP disclosed
US-20260035494-A1 METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS GOODYEAR TIRE & RUBBER (US) 2026-02-05 US disclosed
US-20260002005-A1 DISULFUR DICHLORIDE AND ALKENYL ETHERS ADDITIVES FOR MOONEY JUMP GOODYEAR TIRE & RUBBER (US) 2026-01-01 US disclosed
US-20260001974-A1 DISULFUR DICHLORIDE AND SILANE/SILOXANE ADDITIVE FOR MOONEY JUMP GOODYEAR TIRE & RUBBER (US) 2026-01-01 US disclosed
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-12-25 US disclosed
US-12410263-B2 Modified high-Cis polybutadiene polymer, related methods and rubber compositions BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-09-09 US disclosed
US-12371516-B2 Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2025-07-29 US disclosed
US-12264232-B2 Modified high-cis polybutadiene polymer, related methods and tire components BRIDGESTONE CORPORATION (JP) 2025-04-01 US disclosed
US-6897270-B2 Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom BRIDGESTONE CORPORATION (JP) 2005-05-24 US disclosed
US-20050038215-A1 Lanthanide-based catalyst composition for producing cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2005-02-17 US disclosed
US-20040116638-A1 Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom BRIDGESTONE CORPORATION (JP) 2004-06-17 US disclosed
CN-1494556-A Continuous process for production of conjugated diene polymers having narrow molecular weight distribution and products therefrom ������������ʽ���� 2004-05-05 CN disclosed
US-6699813-B2 COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS BRIDGESTONE CORPORATION (JP) 2004-03-02 US disclosed
EP-1370593-A1 CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM Bridgestone Corporation (JP) 2003-12-17 EP disclosed
US-20030176276-A1 Lanthanide-based catalyst composition for the manufacture of polydienes BRIDGESTONE CORPORATION (JP) 2003-09-18 US disclosed
WO-2002068484-A1 CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM BRIDGESTONE CORPORATION (JP) 2002-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035494-A1 METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS ITGA1, HSPA1A, SHC1 CA2 2428/4885CA4 3266/4885CA5A 4333/4885
US-20260001974-A1 DISULFUR DICHLORIDE AND SILANE/SILOXANE ADDITIVE FOR MOONEY JUMP DCLRE1A, DDR1, FDFT1 CA2 2748/4885CA4 3151/4885CA5A 4655/4885
US-20260002005-A1 DISULFUR DICHLORIDE AND ALKENYL ETHERS ADDITIVES FOR MOONEY JUMP MRE11, DDR1, DDB1 CA2 2684/4885CA4 3250/4885CA5A 4746/4885
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS MALT1, INO80C, RTCB CA2 2025/4885CA4 1685/4885CA5A 2698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.